Metastatic Breast Cancer
Clinical Trial - Nashville
Have you taken Ibrance® or Kisqali®? The Amelia 1 clinical trial is OPEN in Nashville for patients with metastatic breast cancer! Please contact the Vanderbilt-Ingram Cancer Center by email or by calling 1-800-811-8480 (please ask about study SDX-0103)
Vanderbilt-Ingram Cancer Center
**Open to Recruitment
2220 Pierce Ave.
777 Preston Research Building
Nashville, TN 37232
or call 1-800-811-8480 (ask about SDX-0103)
Principal Investigator: Dr. Brent Rexer
Has Your Breast Cancer Spread Despite CDK 4/6 Treatment?
The Amelia 1 breast cancer clinical trial is testing patients with the PIK3CA gene mutation. Post-menopausal women with advanced or metastatic breast cancer who live in the Toledo area are invited to apply to join the trial. Please contact the Toledo Clinic Clinical Research today, using the above information, for more details.
Amelia 1 is a clinical study developed by SynDevRx, Inc.
SynDevRX, Inc. Copyright 2022
Terms of Use
|
Privacy Policy
View our Clinical Trial Site Pages below for more details
